Pharma & Biotech News #PharmaBuzz

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Weekly News Recap #Phispers

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1207

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2049

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

Impressions : 1298

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

In Phispers this week, the US Food and Drug Administration (FDA) approved Eli Lilly’s Foundayo (orforglipron), a once-dai...

Impressions : 1144

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

Lilly in US$ 7.8 bn deal to acquire Centessa for its sleep disorder pipeline; bags FDA nod for obesity med orforglipron

Hainan's Generics Tigecycline Receives Tentative Approval in US

Anthea Pharma's Generics Bupivacaine HCl Receives Approval in US

Shuangcheng's Generics Pantoprazole Na Receives Approval in US

Omsav Pharma's Generics Flecainide Receives Approval in US

Micro's Generics Escitalopram Oxalate Receives Approval in US

Laurus's Generics Valsartan Receives Approval in US

Apotex's Generics Multiple Vitamins Inj Receives Approval in US

Torrent's Generics Vericiguat Receives Tentative Approval in US

Merck Sharp And Dohme's Idvynso Receives Approval in US

Sandoz's Generics Enzalutamide Receives Approval in US

Enforcement Report - Week of April 22, 2026

Veyx-Pharma B.V. Production Fails EDQM Inspection

Produlab Pharma Production Fails EDQM Inspection

Thrive Health and Wellness' Receives FDA Warning Letter

Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter

Apollo Care's Receives FDA Warning Letter

UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter

RC Outsourcing's Receives FDA Warning Letter

Par Health's Receives FDA Warning Letter

Cabio Biotech Wuhan is on FDA Import Alert List

FDA moves to fast-track psychedelic drugs after Trump order

Johnson & Johnson to offer four prescription medicines on TrumpRx

MiKART, Benuvia Partner for Controlled Drug Solutions

Merck goes with Google for AI push, strikes $1B enterprise deal

Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda

AbbVie to build $1.4B manufacturing campus in North Carolina

Valion Bio Completes Transformation To Late-Stage Biopharma

Sun Pharma Wins Trademark Case Against Navi Mumbai Company

Nektar Therapeutics Closes $373.8M Public Offering

Inizio unveils next-generation Hub Services

Cipla's generic Ventolin HFA secures USFDA approval

Novartis' Lutathera Radioligand Therapy Faces Generic Rivals

OGD Director Touts Drop In Refuse-To-Receive Determinations

NRx Pharma Receives Favorable FDA Ogd Feedback

Medicines360, Pharma Dynamics Launch Avibela In South Africa

Lupin Launches Generic Anti-Diabetic Tablets In US

Onesource And Orbicular Secure USFDA Tentative Approval

ANI Pharma Launches Pimozide Tablets with 180-Day CGT Exclusivity

Trump set to restrictions on psychedelic drug used to treat PTSD

Aurobindo Pharma Gets USFDA Nod For Glycerol Phenylbutyrate

Merck goes with Google for AI push, strikes $1B enterprise deal

Merck, Rivals Eye Inhibrx Experimental Drug Tied to Keytruda

AbbVie to build $1.4B manufacturing campus in North Carolina

Valion Bio Completes Transformation To Late-Stage Biopharma

Nektar Therapeutics Closes $373.8M Public Offering

BioLife Solutions: Q1 2026 Results and Business Update on May 7

AbbVie Provides Update on TrenibotE BLA in the US

Sanofi has 'vigorous defense planned' for Dupixent patent cliff

Novo Eyes Adolescent Diabetes Approval for Oral Semaglutide

Trump announces Drug Pricing Deal with Regeneron

MiKART, Benuvia Partner for Controlled Drug Solutions

Supriya Lifescience Gets USFDA EIR For Lote Parshuram Site

Rusan Pharma secure Japan PMDA GMP approval for API, FDF facility

Iran War Impact: Essential Drugs May Cost Up To 5% More, For Now

SQ Innovation And FIS Strike Supply Deal For Furosemide API

FDA Accepts NorthStar's DMF for No-Carrier-Added AC-225

Integrating R&D and Manufacturing in API Development

Iran Conflict: Pharma Chains Face Months-Long Recovery

Government Boosts Pharma Feedstock Amid West Asia Tensions

What Affects Pirfenidone API Pricing? A Buyer's Perspective

Probe Urged As Badlapur Fertility Injection Scam Unveiled

Pharma Files Citizen Petition Against Fda Rejection Letters

Citizen Petition Calls On FDA To Tighten Up CRL Disclosures

FDA Addresses Resourcing Issues Amid Rise In 2025 Class I Recalls

Omega Pharma Ltd Recalls Napralief 250Mg Gastro-Resistant Tablets

Grace Therapeutics Updates On Gtx-104 Drug Application

Different Packaging, Typos Expose Fake Mounjaro Racket

Pharma Petition Urges FDA Reform On Drug Rejection Letter

USFDA Issues Form-483 To Ajanta Pharma's Paithan Facility

Govt Ammonia Rule Curbs Pharma Surplus Sales to Fertiliser Firms

Conavi Medical Awarded 2026 TAG Innovation Award

Cortec's Brain Interchange Joins FDA (TAP) Program

SS Innovations Reveals Advanced Surgical Robotics At SMRSC 2026